Wion RK, Hill NL, Mogle J, Bhargava S, Berish D, Kolanowski A. Scoring of leisure activities for older adults according to cognitive, physical, and social components. Res Gerontol Nurs. 2020 Jan 1;13(1):13-20. doi: 10.3928/19404921-20191022-01
Davis AE, Brogan AJ, Goodwin B, Nocea G, Lozano V. Short-term cost and efficiency analysis of raltegravir versus atazanavir/ritonavir or darunavir/ritonavir for treatment-naive adults with HIV-1 infection in Spain. HIV Clin Trials. 2017 Nov;18(5-6):214-22. doi: 10.1080/15284336.2017.1402144
Kurosky SK, Davis KL, Galindo CM. Effect of combination vaccines on hepatitis B vaccine compliance in children in the United States. Pediatr Infect Dis J. 2017 Jul;36(7):e189-96. doi: 10.1097/INF.0000000000001548
Abeysinghe S, Margulis AV, Mauskopf J, Ainsworth C. Risk factors for RSV hospitalization in healthy preterm infants: a meta-analysis. Letter to the editor. Pediatr Infect Dis J. 2017 Jul;36(7):696. doi: 10.1097/INF.0000000000001559
Mauskopf J, Margulis AV, Samuel M, Lohr KN. Respiratory syncytial virus hospitalizations in healthy preterm infants: systematic review. Pediatr Infect Dis J. 2016 Jul;35(7):e229-38. doi: 10.1097/INF.0000000000001163
Brogan AJ, Mrus J, Hill A, Sawyer AW, Smets E. Comparative cost-efficacy analysis of darunavir/ritonavir and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in the United States. HIV Clin Trials. 2010 May;11(3):133-44.